BioNexus Gene Lab Corp. (BGLC)
- Previous Close
0.5995 - Open
0.5800 - Bid 0.4135 x 200
- Ask 0.7543 x 200
- Day's Range
0.5800 - 0.5999 - 52 Week Range
0.0800 - 9.4900 - Volume
57,000 - Avg. Volume
277,152 - Market Cap (intraday)
10.249M - Beta (5Y Monthly) 1.95
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1800 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
www.bionexusgenelab.com30
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BGLC
Performance Overview: BGLC
Trailing total returns as of 5/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BGLC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BGLC
Valuation Measures
Market Cap
10.25M
Enterprise Value
4.45M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.94
Price/Book (mrq)
1.06
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-26.91%
Return on Assets (ttm)
-12.68%
Return on Equity (ttm)
-32.21%
Revenue (ttm)
9.77M
Net Income Avi to Common (ttm)
-2.63M
Diluted EPS (ttm)
-0.1800
Balance Sheet and Cash Flow
Total Cash (mrq)
5.93M
Total Debt/Equity (mrq)
1.52%
Levered Free Cash Flow (ttm)
566.75k
Research Analysis: BGLC
Company Insights: BGLC
BGLC does not have Company Insights